DRP1 serine 616 phosphorylation is sufficient to actuate mitochondrial dysfunction in transformed cells, dichotomize wild-type BRAF (BRAFWt) and BRAFV600E melanoma tissues, and also broadly impacts upon cancers arising from the brain, breast, and pancreas17–20. This evidence concerns the gene DNM1L and melanoma.